Literature DB >> 3661677

Immunohistochemical localization of metallothionein in human thyroid tumors.

N Nartey1, M G Cherian, D Banerjee.   

Abstract

High levels of metallothionein (MT) are present in the developing mammalian liver; however, a remarkable decrease is observed during postnatal life after weaning. This developmental profile is similar to that of certain oncofetal gene products such as alpha-fetoprotein, which is used as a tumor marker. This study deals with the reexpression of MT genes in thyroid tumors. With an immunohistochemical method, the presence of MT was investigated in tissue sections of normal and neoplastic human thyroid glands. Tissue sections of 34 thyroid tumors and 10 normal human thyroid glands were studied by means of the peroxidase-antiperoxidase method. MT was localized in 31 of the thyroid gland tumors. MT was also present in two of the normal thyroid glands. These findings indicate that although high levels of MT are mainly found in the fetal liver, it may also be expressed actively in certain human thyroid neoplastic tissues, and occasionally in normal thyroid tissue.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3661677      PMCID: PMC1899699     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  22 in total

1.  Cross-reactivity of metallothioneins from different origins with rabbit anti-rat hepatic metallothione in antibody.

Authors:  C Tohyama; Z A Shaikh
Journal:  Biochem Biophys Res Commun       Date:  1978-10-30       Impact factor: 3.575

2.  Radioimmunoassay of metallothioneins.

Authors:  R J Vander Mallie; J S Garvey
Journal:  J Biol Chem       Date:  1979-09-10       Impact factor: 5.157

3.  Distribution of copper and zinc in the liver of the developing sheep foetus.

Authors:  I Bremner; R B Williams; B W Young
Journal:  Br J Nutr       Date:  1977-07       Impact factor: 3.718

4.  A metallothionein-like protein in the hepatic cytosol of the term rat fetus.

Authors:  J U Bell
Journal:  Toxicol Appl Pharmacol       Date:  1979-03-30       Impact factor: 4.219

5.  Equine hepatic and renal metallothioneins. Purification, molecular weight, amino acid composition, and metal content.

Authors:  J H Kägi; S R Himmelhoch; P D Whanger; J L Bethune; B L Vallee
Journal:  J Biol Chem       Date:  1974-06-10       Impact factor: 5.157

6.  Preparation and properties of the major copper-binding component in human fetal liver. Its identification as metallothionein.

Authors:  L Rydén; H F Deutsch
Journal:  J Biol Chem       Date:  1978-01-25       Impact factor: 5.157

7.  The induction of metallothionein in rat liver by zinc injection and restriction of food intake.

Authors:  I Bremner; N T Davies
Journal:  Biochem J       Date:  1975-09       Impact factor: 3.857

8.  Biological function of metallothionein. V. Its induction in rats by various stresses.

Authors:  S H Oh; J T Deagen; P D Whanger; P H Weswig
Journal:  Am J Physiol       Date:  1978-03

9.  Human fetal liver contains both zinc- and copper-rich forms of metallothionein.

Authors:  J R Riordan; V Richards
Journal:  J Biol Chem       Date:  1980-06-10       Impact factor: 5.157

10.  Concentrations of metallothionein and metals in malignant and non-malignant tissues in human liver.

Authors:  S Onosaka; K S Min; C Fukuhara; K Tanaka; S Tashiro; I Shimizu; M Furuta; T Yasutomi; K Kobashi; K Yamamoto
Journal:  Toxicology       Date:  1986-03       Impact factor: 4.221

View more
  18 in total

1.  Localization of zinc and metallothionein in the rat bladder epithelium during carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.

Authors:  X H Zhang; L Jin; I Takenaka
Journal:  Urol Res       Date:  1996

2.  Induction of drug resistance to gold sodium thiomalate in a monocyte cell line, THP-1.

Authors:  Y Ichibangase; M Yamamoto; M Yasuda; N Houki; M Nobunaga
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

3.  Radioimmunoassay of metallothionein in rabbit, rat, mouse, Chinese hamster, and human cells.

Authors:  M E Leibrandt; J Koropatnick; J F Harris; M G Cherian
Journal:  Biol Trace Elem Res       Date:  1991-09       Impact factor: 3.738

4.  Immunohistochemical localization of metallothionein in human testicular embryonal carcinoma cells.

Authors:  T E Kontozoglou; D Banerjee; M G Cherian
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

5.  Immunohistochemical study of metallothionein in pancreatic carcinomas.

Authors:  G Ohshio; T Imamura; N Okada; Z H Wang; K Yamaki; T Kyogoku; H Suwa; H Yamabe; M Imamura
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

6.  Localization of metallothionein in breast carcinomas. An immunohistochemical study.

Authors:  M Fresno; W Wu; J M Rodriguez; M Nadji
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

7.  Overexpression of HIF-1α, metallothionein and SLUG is associated with high TNM stage and lymph node metastasis in papillary thyroid carcinoma.

Authors:  Ni Wang; Chao-Ran Dong; Rong Jiang; Cui Tang; Lei Yang; Qi-Feng Jiang; George G Chen; Zhi-Min Liu
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

8.  Differential expression of metallothionein 1 and 2 isoforms in breast cancer lines with different invasive potential: identification of a novel nonsilent metallothionein-1H mutant variant.

Authors:  Siew-Kian Tai; Owen June-Keong Tan; Vincent Tak-Kwong Chow; Rongxian Jin; J Louise Jones; Puay-Hoon Tan; Anita Jayasurya; Boon-Huat Bay
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

9.  A mutant mouse (tx) with increased hepatic metallothionein stability and accumulation.

Authors:  J Koropatnick; M G Cherian
Journal:  Biochem J       Date:  1993-12-01       Impact factor: 3.857

10.  Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast.

Authors:  K W Schmid; I O Ellis; J M Gee; B M Darke; W E Lees; J Kay; A Cryer; J M Stark; A Hittmair; D Ofner
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.